Alpha Cognition Inc. revenue
Alpha Cognition Inc.'s revenue was $10.2m in fiscal 2025. Over the last twelve months it was $15.3m.
Revenue history
Where the revenue comes from
| Line of business | Revenue | YoY |
|---|---|---|
| Product Net | $6.8M | — |
| Licenses | $3.4M | — |
| Licensing | $598,430 | — |
These categories overlap or exclude eliminations, so shares aren't shown.
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $6.8M | 66.5% | — |
| China | $3.4M | 33.5% | — |
From Alpha Cognition Inc.'s 10-K filed March 31, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Alpha Cognition Inc. | $15.3m | — | — |
| Keros Therapeutics, Inc. | $14.9m | -93.6% | — |
| Alector, Inc. | $13.9m | -82.9% | -48.6% |
| Lineage Cell Therapeutics, Inc. | $13.1m | 19.9% | 7.5% |
| Proqr Therapeutics N.V. | $18.0m | -12.1% | — |
| Cytomx Therapeutics, Inc. | $18.3m | -87.0% | -38.7% |
Compare with peers
- Keros Therapeutics, Inc. revenue
- Alector, Inc. revenue
- Lineage Cell Therapeutics, Inc. revenue
- Proqr Therapeutics N.V. revenue
- Cytomx Therapeutics, Inc. revenue
Head to head: ACOG vs KROSACOG vs ALECACOG vs LCTX
More: Biotechnology stocks compared, Health Care sector, rankings of US companies